KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

GoodRx Holdings (GDRX) Receivables Refunds (2020 - 2022)

GoodRx Holdings' Receivables Refunds history spans 3 years, with the latest figure at $4.5 million for Q4 2022.

  • On a quarterly basis, Receivables Refunds fell 45.7% to $4.5 million in Q4 2022 year-over-year; TTM through Dec 2022 was $4.5 million, a 45.7% decrease, with the full-year FY2022 number at $4.5 million, down 45.7% from a year prior.
  • Receivables Refunds hit $4.5 million in Q4 2022 for GoodRx Holdings, up from $2.2 million in the prior quarter.
  • Over the last five years, Receivables Refunds for GDRX hit a ceiling of $79.8 million in Q2 2021 and a floor of $2.2 million in Q3 2022.
  • Historically, Receivables Refunds has averaged $24.4 million across 3 years, with a median of $22.3 million in 2021.
  • Biggest five-year swings in Receivables Refunds: dropped 3.09% in 2021 and later tumbled 92.24% in 2022.
  • Tracing GDRX's Receivables Refunds over 3 years: stood at $28.6 million in 2020, then crashed by 70.83% to $8.3 million in 2021, then tumbled by 45.7% to $4.5 million in 2022.
  • Business Quant data shows Receivables Refunds for GDRX at $4.5 million in Q4 2022, $2.2 million in Q3 2022, and $16.8 million in Q2 2022.